Swedish Macrolane Registry

Galderma

Status: Completed

Conditions: Breast Augmentation

Study type: Observational

Funder types: Industry

Identifiers

NCT01145235

31GB0905

Details and patient eligibility

About

A Registry to monitor long term safety in female subjects after treatment with Macrolane VRF20 and/or MacrolaneT VRF30 in the breasts.

Enrollment: 1,300 patients

Sex: Female

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

1. Females previously treated with Macrolane VRF in the breasts
2. Females continuously being treated with Macrolane VRF in the breasts, initial treatment or re-treatment.

Exclusion criteria

No exclusion criteria

Trial design

1,300 participants in 1 patient group

Females previously treated with Macrolane in their breasts.